Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note
Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note

Adma Biologics (ADMA) closed the most recent trading day at $8.59, moving -1.83% from the previous trading session. This move lagged the S&P 500's daily gain of 0.89%. Elsewhere, the Dow gained

Adma Biologics (ADMA) Rises Higher Than Market: Key Facts
Adma Biologics (ADMA) Rises Higher Than Market: Key Facts

In the latest trading session, Adma Biologics (ADMA) closed at $8.48, marking a +2.54% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.02%

Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note
Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note

In the latest close session, Adma Biologics (ADMA) was down 2.42% at $8.46. This change lagged the S&P 500's daily gain of 0.7%. Meanwhile, the Dow experienced a rise of 0.53%, and the

Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note
Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note

In the latest close session, Adma Biologics (ADMA) was down 2.42% at $8.46. This change lagged the S&P 500's daily gain of 0.7%. Meanwhile, the Dow experienced a rise of 0.53%, and the

ADMA Biologics Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Specialty food store, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/7a8f69d5-c26e-46d9-b403-d3e5e9562eca.png
ADMA Biologics Q2 Earnings Call Highlights

Key Points

Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest?
Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm